33246059|t|Inflammatory Cytokine IL-1beta Downregulates Endothelial LRP1 via MicroRNA-mediated Gene Silencing.
33246059|a|Effective clearance of neurotoxic amyloid-beta (Abeta) from the brain is a critical process to prevent Alzheimer's disease (AD). One major clearance mechanism is Abeta transcytosis mediated by low-density lipoprotein receptor-related protein 1 (LRP1) in capillary endothelial cells. A marked loss of endothelial LRP1 is found in AD brains and is believed to significantly impair Abeta clearance. Recently, we demonstrated that pro-inflammatory cytokines IL-1beta, IL-6 and TNF-alpha, significantly down-regulated LRP1 in human primary microvascular endothelial cells (MVECs). In this study, we sought to determine the underlying molecular mechanism by which IL-1beta led to LRP1 loss in MVECs. Reduced LRP1 protein and transcript were detected up to 24 h post-exposure and returned to the baseline levels after 48 h post-exposure with 1 ng/ml IL-1beta. This reduction was in part mediated by microRNA-205-5p, -200b-3p, and -200c-3p, as these microRNAs were concomitantly upregulated in MVECs exposed to IL-1beta. Synthetic microRNA-205-5p, -200b-3p, and -200c-3p mimics recapitulated LRP1 loss in MVECs without IL-1beta, and their synthetic antagomirs effectively reversed IL-1beta-mediated LRP1 loss. Importantly, we found that the expression of these three microRNAs was controlled by NF-kappaB as pharmacological NF-kappaB inhibitor, BMS-345541, inhibited the IL-1beta-mediated upregulation of these microRNAs and rescued LRP1 expression. siRNA-mediated silencing of IkappaB in MVECs elevated microRNA-200b-3p and decreased LRP1 transcript, partially confirming our overall findings. In conclusion, our study provides a mechanism by which pro-inflammatory IL-1beta instigates the suppression of LRP1 expression in MVECs. Our findings could implicate spatiotemporal loss of LRP1 and impairment of the LRP1-mediated clearance mechanism by endothelial cells.
33246059	0	12	Inflammatory	Disease	MESH:D007249
33246059	22	30	IL-1beta	Gene	3553
33246059	57	61	LRP1	Gene	4035
33246059	123	133	neurotoxic	Disease	MESH:D020258
33246059	134	146	amyloid-beta	Gene	351
33246059	148	153	Abeta	Gene	351
33246059	203	222	Alzheimer's disease	Disease	MESH:D000544
33246059	224	226	AD	Disease	MESH:D000544
33246059	262	267	Abeta	Gene	351
33246059	293	343	low-density lipoprotein receptor-related protein 1	Gene	4035
33246059	345	349	LRP1	Gene	4035
33246059	412	416	LRP1	Gene	4035
33246059	429	431	AD	Disease	MESH:D000544
33246059	479	484	Abeta	Gene	351
33246059	531	543	inflammatory	Disease	MESH:D007249
33246059	554	562	IL-1beta	Gene	3553
33246059	564	568	IL-6	Gene	3569
33246059	573	582	TNF-alpha	Gene	7124
33246059	613	617	LRP1	Gene	4035
33246059	621	626	human	Species	9606
33246059	758	766	IL-1beta	Gene	3553
33246059	774	778	LRP1	Gene	4035
33246059	802	806	LRP1	Gene	4035
33246059	943	951	IL-1beta	Gene	3553
33246059	1103	1111	IL-1beta	Gene	3553
33246059	1184	1188	LRP1	Gene	4035
33246059	1211	1219	IL-1beta	Gene	3553
33246059	1273	1281	IL-1beta	Gene	3553
33246059	1291	1295	LRP1	Gene	4035
33246059	1387	1396	NF-kappaB	Gene	4790
33246059	1416	1425	NF-kappaB	Gene	4790
33246059	1437	1447	BMS-345541	Chemical	MESH:C471109
33246059	1463	1471	IL-1beta	Gene	3553
33246059	1525	1529	LRP1	Gene	4035
33246059	1627	1631	LRP1	Gene	4035
33246059	1746	1758	inflammatory	Disease	MESH:D007249
33246059	1759	1767	IL-1beta	Gene	3553
33246059	1798	1802	LRP1	Gene	4035
33246059	1876	1880	LRP1	Gene	4035
33246059	1903	1907	LRP1	Gene	4035
33246059	Association	3553	4790
33246059	Positive_Correlation	MESH:C471109	4035
33246059	Association	MESH:D007249	3553
33246059	Negative_Correlation	3569	4035
33246059	Negative_Correlation	MESH:C471109	4790
33246059	Association	351	4035
33246059	Association	MESH:D000544	351
33246059	Negative_Correlation	MESH:D000544	4035
33246059	Negative_Correlation	4035	7124
33246059	Negative_Correlation	MESH:C471109	3553
33246059	Negative_Correlation	MESH:D007249	4035
33246059	Association	4035	4790
33246059	Negative_Correlation	3553	4035

